Actively Recruiting
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
Led by Monell Chemical Senses Center · Updated on 2025-04-16
100
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
Sponsors
M
Monell Chemical Senses Center
Lead Sponsor
N
NIAID, Division of AIDS (contract funder)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Many people, particularly small children, must take drugs in liquid form because they cannot swallow pills or capsules. The bad taste of some liquid drugs can keep patients from taking drugs they need for their health. Our main goal in this research study is find ingredients that might make drugs taste better. Participants in this research study will be healthy adults between the ages of 18 and 60 years old. Participants will taste samples (liquids or gels) containing active pharmaceutical ingredients (substances in medications that produce desired health effects). After tasting each sample participants will spit out the sample and rinse with water (no samples will be swallowed). Active pharmaceutical ingredients of current interest are: 1) tenofovir alafenamide, used to treat HIV infection and hepatitis B, 2) rifampicin, used to treat tuberculosis, 3) rifapentine, used to treat tuberculosis, and 4) levofloxacin, used to treat various bacterial infections). Other active pharmaceutical ingredients may be added as the study goes forward. Participants will be instructed to taste samples both with and without experimental flavor ingredients added and judge how the samples taste. People who volunteer for the study will be instructed to complete many repeated visits to the Monell Center (University City area of Philadelphia) for tasting sessions. Tasting visits will last between 1 and 2 hours.
CONDITIONS
Official Title
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 18 and 60
- Generally healthy by self-report
- All races/ethnicities, both men and women
- Able to provide informed consent
- Able to attend repeated visits to Monell for sensory testing
- Willing to follow instructions such as refraining from eating or drinking for at least 1 hour before sessions and remaining on site for one hour after tasting a new active pharmaceutical ingredient
You will not qualify if you...
- Under 18 or over 60 years old
- Pregnant, nursing, or planning to become pregnant
- Unable to provide consent, including limited ability to understand written and spoken English
- Regular users of tobacco, vape, marijuana, or THC cartridges (occasional use allowed)
- Known drug or food allergies
- Diabetes or other metabolic disorders
- Liver problems, including viral hepatitis
- Kidney problems
- Other chronic illnesses such as cardiovascular, neurological, or immune disorders
- Dentures or major dental implants
- Conditions affecting the mouth such as dry mouth, burning mouth syndrome, active sores or blisters, geographic tongue
- Current infection, cold, flu, or COVID-19 infection within the last 4 weeks
- Unable to taste or smell
- Daily use or use within the last 4 weeks of prescription or over-the-counter medications (except birth control)
- History of tuberculosis, positive TB tests, or exposure to tuberculosis
- HIV infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Monell Chemical Senses Center
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
P
Paul M Wise, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here